Blog

Jul 21 min read

THE EUROPEAN SOCIETY OF MEDICINE

Amyotrophic Lateral Sclerosis is a spectrum of diseases that needs a broad treatment approach Siobhan P Ellison DVM PhD1

May 222 min read

Clinical Trial FC-US-001

June 21, 2024 The last subjects for the clinical trial using FC-12738, affectionally called TVALA, had their final follow up visit on ...

May 222 min read

Richard H Helms 1949-2024

In hindsight, Richard Helms remembered he had a non-painful limp in 2018. After multiple consults he was introduced to ALS, that was in...

Mar 51 min read

TVALA Drug Trial

We are happy to announce the first patients are being screened for entry into the clinical trial for our drug TVALA! This Phase 1 study...

Dec 19, 20232 min read

MOLECULAR MECHANISMS OF REDOX REGULATION IN INFLAMMATION

We are hopeful that TVALA will reduce p53 expression in people with ALS. There are two recent publications that give us hope. The first...

Dec 1, 20231 min read

TVALA Fortune Journal

Pharmacological Characterization of FC-12738: A Novel Retro-Inverso Pentapeptide for Treating Neuroinflammation

Aug 10, 20231 min read

NDR starts clinical trial with TVALA

Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS....

Mar 21, 20231 min read

First Biomarkers Identified to Measure ALS Disease Progression and Therapeutic Response

https://www.houstonmethodist.org/leading-medicine-blog/articles/2022/sep/first-biomarkers-identified-to-measure-als-disease-progression-a...